Effect of Upper Eyelid Surgeries on Corneal Characteristics

Status Recruiting

Clinical Trial Summary

The goal of this prospective observational study is to learn about the impact of conventional eyelid correction surgery on the eye's health and function in ptosis and eyelid retraction patient. The main questions it aims to answer are: • 1. Changes in corneal topography, higher-order corneal aberrations, corneal biomechanical characteristics, and corneal epithelial thickness before and after the surgery 2. Influence of corneal refraction examinations , vision change, and tear film function after the surgery Fifty participants will undergo conventional eyelid correction surgery by the same ophthalmologist (YH Wei) and non-invasive examinations before and after the surgery. The patient will be separate to 2 groups, including 30 with correction for ptosis and 20 with correction for eyelid retraction. The research will collect information of the operated eye and fellow eye, and the data will be compared between operated and fellow eye and with the other group.

Clinical Trial Description

The position of the upper eyelid affects the health and function of the eye. Ptosis can obstruct the vision, and eyelid retraction can result in the loss of proper protection of the ocular surface. Through conventional upper eyelid correction surgery, the height of the upper eyelid can be adjusted to a proper position. However, after upper eyelid surgery, the pressure of the upper eyelid on the corneal surface may change, affecting corneal topography, higher-order corneal aberrations, corneal biomechanical characteristics, and corneal epithelial thickness. These changes may affect postoperative vision and visual quality. The impact of upper eyelid surgery on corneal refraction and corneal biomechanical characteristics remains inconclusive in current studies, and the impact on corneal epithelial thickness is even less investigated. This is a prospective observational study, expecting to enroll 50 patients who have undergone upper eyelid surgery, including 30 for ptosis correction and 20 for eyelid retraction correction. Non-invasive examinations will be used to assess changes in corneal topography, higher-order corneal aberrations, corneal biomechanical characteristics, and corneal epithelial thickness before and after the surgery to understand the impact of upper eyelid surgery on the ocular surface and the possible mechanism or influencing factors of postoperative vision changes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05750251
Study type	Observational [Patient Registry]
Source	National Taiwan University Hospital
Contact	Yi-Hsuan Wei, PhD
Phone	+886-2312-3456
Email	ericwei224@hotmail.com
Status	Recruiting
Phase
Start date	February 6, 2023
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01190397` - Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy	Phase 1
Withdrawn	`NCT05672407` - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery	Phase 4
Completed	`NCT03199911` - Topical Antibiotic Prophylaxis for Eyelids	Phase 4
Recruiting	`NCT04689230` - Small Incision Technique Versus Upper Blepharoplasty in Upper Eyelid Medial Pad Fat Removal	N/A
Completed	`NCT01091311` - Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases	Phase 4
Recruiting	`NCT04359979` - Tamsulosin for Thyroid Lid Retraction	N/A
Not yet recruiting	`NCT06279143` - The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
Recruiting	`NCT04102878` - Transconjunctival vs Transcutaneous Anaesthesia in Oculoplastics	N/A
Completed	`NCT01189474` - Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases	Phase 4
Active, not recruiting	`NCT04149210` - FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial	Phase 3
Not yet recruiting	`NCT04235803` - Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery	N/A
Completed	`NCT04554329` - Bandage Contact Lenses Versus Eye Patching of Müller's Muscle-conjunctival Resection	N/A
Recruiting	`NCT04898933` - Patient Satisfaction After Eyelid Lesion Excision
Recruiting	`NCT04861454` - Brassiere Brow Suture and Internal Browpexy
Recruiting	`NCT04201925` - Functional Changes After Upper Blepharoplasty
Recruiting	`NCT04255667` - Eyelid Crush for Marginal Eyelid Surgery
Recruiting	`NCT05016362` - Medial Fat Pad Preservation in Upper Eyelid Blepharoplasty
Recruiting	`NCT05945069` - Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects With Dry Eye Disease	N/A
Recruiting	`NCT04140734` - Spacer Graft Study	N/A
Recruiting	`NCT04720586` - Surgical Treatment of Lower Eyelid Involutional Entropion and Dermatochalasis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.